Clinical Trials · NCT06020456

Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A

Phase
N/A
Recruitment status
Completed
Sponsor
Groupe Maladies hémorragiques de Bretagne
Enrollment
361
Start date
Jan 2022
Locations
12 sites, France
Primary endpoint
Comparison of the post-DDAVP FVIII peak in patients of the group "Null variants" vs "No Null variants"
View Desmopressin compound reference